About Nobil Bio
Nobil Bio is a Healthcare company based in Asti (Italy) founded in 1994, and was acquired by Lifco in October 2025. Surface treatments and biomaterials for dental implants are developed. Nobil Bio offers products and services including Surface Treatment for Dental Implants and Synergoss. Its focus areas include Biopharma Outsourcing. Its legal entity is Nobil Bio Ricerche S.r.l.
Company details
Nobil Bio was founded in 1994 in Asti, Italy, as a research-driven entity in the biomaterials sector. Surface modifications of titanium implants are provided through biochemical methods to support bone regeneration. Processes involving controlled microtopography and surface chemistry are utilized to improve implant integration. Operations focus on dental implant enhancements, with services extending to specialized surface treatments for medical applications in Europe.
- Headquarters Asti, Italy
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nobilbio.it
- Social Facebook
- Acquired by Lifco (Oct 2025)
- Legal Name Nobil Bio Ricerche S.R.L
- Latest Funding Round$354.79K (USD), Grant
Nov 2015
- InvestorsEuropean Union
& 1 more
- Acquired byLifco
(Oct 2025)
Products & Services of Nobil Bio
Nobil Bio offers a comprehensive portfolio of products and services, including Surface Treatment for Dental Implants and Synergoss.
Process for enhancing dental implants through surface modification.
Bone filler material for regenerative osseointegration purposes.
Funding Insights of Nobil Bio
- Total Rounds 1
- Last Round Grant — $354,792
- First Round $354,792
(Nov 2015)
- Investors Count 1
All 1 funding rounds of Nobil Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2015 | $354,792 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Nobil Bio
Nobil Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Lifco.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Dental equipment and supplies are distributed by Lifco in Sweden. | 1946 | lifco.se | Enkoping, Sweden |
Investor details for Nobil Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Nobil Bio
3 dated milestones of Nobil Bio across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Nobil Bio is founded.
- Funding First funding round of $355K.
- Exit Acquired by Lifco.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nobil Bio
Nobil Bio was founded in 1994 and raised its 1st funding round 21 years after it was founded.
Nobil Bio is headquartered in Asti, Italy. It is registered at Asti, Piemonte, Italy.
Nobil Bio was founded in 1994 in Asti, Italy, as a research-driven entity in the biomaterials sector. Surface modifications of titanium implants are provided through biochemical methods to support bone regeneration. Processes involving controlled microtopography and surface chemistry are utilized to improve implant integration. Operations focus on dental implant enhancements, with services extending to specialized surface treatments for medical applications in Europe.
Nobil Bio offers Surface Treatment for Dental Implants and Synergoss.
Nobil Bio has 2 investors. Key investors include European Union, and Lifco.
Nobil Bio operates through Nobil Bio Ricerche S.R.L.
Yes. Nobil Bio was acquired by Lifco in October 2025.